LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| BT-20 | Linifanib | -0.0159 |
| BT-20 | Linsitinib | 0.1092 |
| BT-20 | Mitoxantrone | 1.0998 |
| BT-20 | MK2206 | 0.3675 |
| BT-20 | Neratinib | 0.4401 |
| BT-20 | Nilotinib | 0.0948 |
| BT-20 | Nintedanib | 0.1562 |
| BT-20 | NU7441 | 0.0953 |
| BT-20 | NVP-AEW541 | -0.0091 |
| BT-20 | Luminespib | 1.0261 |
| BT-20 | NVP-TAE684 | 0.2851 |
| BT-20 | OSI-027 | 0.4435 |
| BT-20 | Palbociclib | 0.6105 |
| BT-20 | PD0325901 | 0.2605 |
| BT-20 | PD173074 | -0.1002 |
| BT-20 | PD184352 | 0.0705 |
| BT-20 | Pelitinib | 0.3310 |
| BT-20 | PF431396 | 0.6479 |
| BT-20 | PF477736 | 0.1690 |
| BT-20 | PF562271 | 0.4338 |
| BT-20 | PHA-665752 | 0.0695 |
| BT-20 | PHA-793887 | 0.8032 |
| BT-20 | PI103 | 0.6846 |
| BT-20 | PIK-93 | 0.1306 |
| BT-20 | PLX-4720 | 0.1515 |